Optiray ioversol injection recalled for particulate matter
Liebel-Flarsheim Company LLC is recalling Optiray Imaging Bulk Package-350 (ioversol injection 74%, 350 mg/mL) due to the presence of particulate matter—including plastic, stainless steel, and glass—found in affected vials. The contamination affects lot #25ZF3670 with an expiration date of May 31, 2027, distributed nationwide in the US and Mexico.
From the FDA notice · Read the official notice ↗
What to do
- Check your facility's inventory for lot #25ZF3670 of Optiray 350 mg/mL vials.
- Do not use affected vials; quarantine them immediately.
- Contact Liebel-Flarsheim or your healthcare provider for guidance on replacement or proper disposal.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65.
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 3,486 500mL-vials
- Illnesses reported
- None reported
- Manufactured in
- 8800 Durant Rd, Raleigh, NC, United States
- Classification
- Class I
- Recall number
- D-0773-2026
In the FDA's words
- Description
- Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65. Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass. Lot # 25ZF3670, Exp Date: May 31, 2027. Distribution: Distributed Nationwide in the US and Mexico. Affected quantity: 3,486 500mL-vials
- Hazard
- Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.